focus -WSS

focus

author：hotspot 2025-10-02 07:05:49 - browse：51

Editor’s note: A recording of the event is embedded below.

Several biosimilar versions of Humira, which for years has been the world’s best-selling medicine, entered the U.S. market over the past year. What has that meant for insurance coverage and the way drugmakers are marketing these medicines? Join leading experts to discuss the impact on the industry and patients.

Sponsor introduction

Thomas Newcomer, vice president and head of U.S. market access, Samsung Bioepis (sponsor)

Featured speakers

Chris M. Brown, president, McAteer
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Fran Gregory, MBA, PharmD, vice president of emerging therapies, Cardinal Health
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)

WSS

Radiology is caught between AI's potential and concern for patients

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Patients' immediate access to test results puts radiologists in a bind

FDA approves world's first CRISPR

Pregnancy ages women, but effects reverse after delivery

Steward Health Care expansion into Malta flopped

leisure time

focus

Sponsor introduction

Featured speakers

Sponsored By

Wikipedia

Virginia high school admissions case could be legal follow

Mirador, a new biotech startup, launches with $400 million

How one medical school became remarkably diverse

Congenital heart disease patients face new threat of heart failure

Hepatitis C has a cure — but many Americans still lack access to it

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

ChatGPT in medicine: STAT answers readers' burning questions

Medical devices makers are asking for forgiveness, not permission

DIEP, the 'gold standard' of breast reconstruction, is under threat

The woman behind the Dana Farber

leisure time

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

After sickle

Pregnancy discrimination could be enabled by AI

Why sickle cell disease is getting the first CRISPR treatment

Congenital heart disease patients face new threat of heart failure

Pharma patents targeted by Biden in move to slash drug prices

focus

explore

Wikipedia

entertainment